DDU of Soft Mist Inhalers (SMIs)
Both MDIs and DPIs suffer from the same two inherent problems: low lung deposits (typically 5-20%) and dose variability (often due to patient difficulties in coordination or inspiration).SMIs (often known as “Inhalation Metered Sprays’’ or “Aqueous Droplet Inhalers”) actively aerosolise the liquid, forming a ‘soft mist’ to overcome these problems. These inhalers generally deliver a higher fine particle fraction than MDIs or DPIs. However, as with any multi-dose liquid system, microbial contamination can be a problem. Since they are active, aqueous-based devices, the DDU testing of ADIs is similar to that of MDIs, with testing carried out at a constant flow rate of 28.3 L/min.
Low Capacity Pump LCP6
View BrochureBreath Actuation Controller BAC 100i
View BrochureInhaler Testing Workstation ITW
View ProductDose Uniformity Sample Apparatus (DUSA) for MDIs
View BrochureFlow Rate Sensor FRS
View BrochureWaste Shot Collector WSC2
View BrochureMouthpiece Adapter
View ProductEnviroMate™ – Benchtop Environmental Chamber
View BrochureFlow Meter DFM 2000
View BrochureDUSA Stand for DPIs
View BrochureTemperature/Humidity Sensor
View BrochureLabel Printer
View BrochureAPSD of Aqueous Droplet Inhalers (ADIs)
View SystemLow Capacity Pump LCP6
View BrochureBreath Actuation Controller BAC 100i
View BrochureInhaler Testing Workstation ITW
View ProductDose Uniformity Sample Apparatus (DUSA) for MDIs
View BrochureFlow Rate Sensor FRS
View BrochureWaste Shot Collector WSC2
View BrochureMouthpiece Adapter
View ProductEnviroMate™ – Benchtop Environmental Chamber
View BrochureFlow Meter DFM 2000
View BrochureDUSA Stand for DPIs
View BrochureTemperature/Humidity Sensor
View BrochureLabel Printer
View BrochureAPSD of Aqueous Droplet Inhalers (ADIs)
View SystemDDU Over the Entire Contents
In the case of multiple dose devices, tests might need to be carried out throughout the life of the inhaler i.e. dose uniformity over the entire contents.
Learn MoreRelated Applications
We also offer a range of equipment for additional MDI testing application support:
Related Applications
Two factors have been identified as being critical to improving the clinical relevance of DDU testing and APSD measurement: realistic breathing profiles and realistic throat and nasal models.
View MoreSemi-Automation Tools
Semi-Automation Tools
All of the tests involved in Delivered Dose Uniformity require the collection and drug recovery of individual doses into the collection tube of a Dosage Unit Sampling Apparatus (DUSA) appropriate to its type (MDI or DPI) prior to assay.
View ProductRelated Services
Training
We offer a range of training courses, presentations and seminars covering a wide range of topics.
Find Out MoreServicing
A comprehensive range of both in-house and on-site product servicing options are available
Find Out MoreSupport
Our team of experienced technicians and engineers are on hand to help and advise
Find Out MoreRelated News & Resources
Copley introduces the new Flow Rate Sensor, a dedicated device for inhaler testing systems.
27th June 2023
Find out more
The new DUSA Shaker™ DTS 100i from Copley: For faster, safer, more repeatable inhaler testing
8th February 2023
Find out more
Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing
14th September 2022
Find out more
Copley Scientific joins the Industries Forum of the Taskforce for Lung Health
22nd June 2021
Find out more
Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio
1st March 2021
Find out more
Understanding the Links Between Drug Delivery Route and In Vitro Test Methods
View download
Reducing Inhaler Testing Variability Through Test Environment Control
View download
Semi-Automating Inhaler Testing – A Good Idea, but Where to Start?
View download
A short Q&A with our CEO, Mark Copley, On Inhaled Product Testing
View download
Optimizing the Role of Automation in Variability Reduction Strategies For Delivered Dose Uniformity (DDU) and Aerodynamic Particle Size Distribution (APSD) Testing of Inhaled Drug Products
View download
The Regulatory Landscape for OINDPs – The Biggest Shake-up in A Generation?
View download
Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products
View download
Demonstrating Bioequivalence of Orally Inhaled Products
View download
Optimising the Application of In Vitro Test Methods for the Demonstration of BE in OIPs
View download
Have a question? Our friendly and experienced team are here to help.